M. Soker et al., Serum levels of IL-1 beta, sIL-2R, IL-6, IL-89 and TNF-alpha in febrile children with cancer and neutropenia, MED ONCOL, 18(1), 2001, pp. 51-57
Serum levels of interleukin-1 beta (IL-1 beta), soluble interleukin 2 recep
tors (sL-2R), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosi
s factor-alpha (TNF-alpha) were measured to predict some characteristics of
febrile episodes in children with cancer and neutropenia. Forty-eight epis
odes of febrile neutropenia were determined in 23 pediatric cancer patients
, including 35 febrile episodes without identifiable source, 7 episodes of
bacteremia due to Gram-negative organisms and 4 due to Gram-positive organi
sms, and 2 fungal infections. Interleukin-6, sIL-2R, and IL-8 levels were s
ignificantly higher at the beginning of the febrile episodes than those of
controls (p<0.001, p<0.001, and p<0.001). Interleukin-6, sIL-21R, and IL-8
levels were higher in patients with bacteremia due to Gram-negative organis
ms than in those with Gram-positive ones (p=0.042, p=0.006, and p=0.023, re
spectively). TNF-<alpha> and IL-1 beta levels were similar in febrile episo
des and controls (p>0.05). In conclusion, sIL-2R, IL-6, and IL-8 levels may
be helpful in the prediction of infection in febrile cancer patients with
neutropenia and measurements of IL-1 beta and TNF-alpha were not useful for
identifying the presence and the type of infection in febrile neutropenic
episodes in children.